BVI Medical completes a $1 billion strategic capital raise

News
Article

The capital raise was completed in partnership with global alternative asset management firm TPH.

Graphic of stock market and coins Image credit: AdobeStock/Kiattisak

Image credit: AdobeStock/Kiattisak

Global ophthalmic device company BVI Medical has announced the completion of its $1 billion strategic capital raise in partnership with global alternative asset management firm TPG. The investment fully refinanced BVI’s existing debt and added new equity from both TPG and new investors.1 The company plans to continue substantial growth in its portfolio of product offerings in light of the investment, according to a news release.

“This investment marks a pivotal moment for BVI as we scale our capabilities to meet the rising demand for advanced ophthalmic solutions,” said Shervin Korangy, president and CEO of BVI, in the release. “We are redefining the future of eye surgery and changing the competitive landscape by driving the launch of breakthrough technologies that will empower surgeons worldwide.”

Of recent note, BVI expanded its IOL manufacturing to Europe in order to meet global product demand, introduced new product lines including SERENITY and SERENITY Toric premium monofocal IOLs,2 and has engaged in a number of strategic acquisitions. Additionally, the company launched an education platform for ophthalmologists earlier this year, which allows physicians to connect across specialties to share insights and address complex cases.3

“TPG is proud to continue our partnership with BVI as it works to scale its global impact in ophthalmic care,” said Kendall Garrison, Partner at TPG. “The company has strengthened its market position while advancing patient care worldwide and this investment will further drive innovation and expansion. We look forward to supporting BVI’s continued success,” added John Schilling, MD, Co-Managing Partner at TPG Capital.

References:
  1. BVI Medical secures strategic capital raise to fuel global growth and innovation. News release. Businesswire. March 10, 2025. Accessed March 12, 2025. https://www.businesswire.com/news/home/20250306731225/en/BVI-Medical-Secures-Strategic-Capital-Raise-to-Fuel-Global-Growth-and-Innovation
  2. Joy J. BVI to launch new SERENITY and SERENITY Toric monofocal IOLs. Optometry Times. September 5, 2024. Accessed March 12, 2025. https://www.optometrytimes.com/view/bvi-to-launch-new-serenity-and-serenity-toric-monofocal-iols
  3. BVI Medical launches educational platform for ophthalmology professionals. News release. News release. BVI Medical. January 31, 2025. Accessed March 12, 2025. https://www.bvimedical.com/us/bvi-medical-launches-educational-platform-for-ophthalmology-professionals/

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Christi Closson, OD, FAAO, shares her excitement for the new Acuvue Oasys MAX 1-Day multifocal for astigmatism
Karen R. Hoffman, OD, speaks on her AOA 2025 poster, which details a case series on fitting patients with irregular cornea and astigmatism with Zenlens (Bausch + Lomb)
Mitch Ibach, OD, FAAO, details a presentation he gave with Tanner Ferguson, MD, at the Collaborative Care Symposium 2025.
Mitch Ibach, OD, FAAO, details the importance of identifying the best candidates and practicing comanagement for refractive surgery.
Mark Bullimore, MCOptom, PhD, details the importance of preparing optometric students for myopic patient care in a Collaborative Care Symposium (CCS) 2025 presentation.
Peter Hersh, MD, stated that the key takeaway from a handful of presentations he gave at CCS 2025 is that successfully treating patients with keratoconus is identifying the disease early.
Susana Marcos, PhD, discusses the implications her research presents for the role optical coherence tomography (OCT) could play in presbyopia and myopia accommodation efforts.
Susana Marcos, PhD, outlines a presentation she gave at ARVO 2025 on a unique utilization of optical coherence tomography.
Dr Luke Lindsell discusses retinal therapy and geographic atrophy at Controversies in Modern Eye Care 2025
Robert Maloney, MD, MA, at the 2025 Controversies in Modern Eye Care meeting
© 2025 MJH Life Sciences

All rights reserved.